E-type prostaglandins and interferons: yin-yang modulation of macrophage tumoricidal activity.

[1]  R. Schultz,et al.  Stimulation and inhibition of neoplastic cell growth by tumor promoter-treated macrophages. , 1980, Cellular immunology.

[2]  K. Trofatter,et al.  Effect of prostaglandins and cyclic adenosine 3',5'-monophosphate modulators on herpes simplex virus growth and interferon response in human cells , 1980, Infection and immunity.

[3]  K. Resch,et al.  Induction of prostaglandin E release from macrophages by colchicine. , 1980, Journal of immunology.

[4]  D. Webb,et al.  Regulation of the immune response by prostaglandins. , 1980, Clinical immunology and immunopathology.

[5]  R. Keller.  Suppression of natural antitumour defence mechanisms by phorbol esters , 1979, Nature.

[6]  R. Schultz,et al.  Selective neutralization by antiinterferon globulin of macrophage activation by L-cell interferon, Brucella abortus ether extract, Salmonella typhimurium lipopolysaccharide, and polyanions. , 1979, Cellular immunology.

[7]  R. Bockman,et al.  Increased prostaglandin synthesis by macrophages from tumor-bearing mice. , 1979, Journal of immunology.

[8]  J. Lindgren,et al.  Production of prostaglandin E2 by bladder tumor cells in tissue culture and a possible mechanism of lymphocyte inhibition. , 1979, Cellular immunology.

[9]  M. Castagna,et al.  Effect of interferon on concentrations of cyclic nucleotides in cultured cells. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Dayer,et al.  Increased prostaglandin production by human monocytes after membrane receptor activation. , 1979, Journal of immunology.

[11]  S. Russell,et al.  Macrophage-mediated tumor cell killing: lack of dependence on the cyclooxygenase pathway of prostaglandin synthesis. , 1979, Journal of immunology.

[12]  R. Schultz,et al.  Role of E-type prostaglandins in the regulation of interferon-treated macrophage cytotoxic activity. , 1979, Journal of the Reticuloendothelial Society.

[13]  M. A. Bray,et al.  Prostaglandin and thromboxane production by human and guinea-pig macrophages and leucocytes. , 1979, Prostaglandins.

[14]  R. Schultz,et al.  Prevention of macrophage tumoricidal activity by agents known to increase cellular cyclic AMP. , 1979, Cellular immunology.

[15]  J. Salomon,et al.  Tumor growth inhibition and potentiation of immunotherapy by indomethacin in mice. , 1979, Journal of the National Cancer Institute.

[16]  M. Meltzer,et al.  Macrophage activation for tumor cytotoxicity: development of macrophage cytotoxic activity requires completion of a sequence of short-lived intermediary reactions. , 1978, Journal of immunology.

[17]  R. Schultz,et al.  Macrophage activation and antitumor activity of a Brucella abortus ether extract, Bru-Pel. , 1978, Cancer treatment reports.

[18]  R. Schultz,et al.  Regulation of macrophage tumoricidal function: a role for prostaglandins of the E series. , 1978, Science.

[19]  D. Stringfellow.  Prostaglandin restoration of the interferon response of hyporeactive animals. , 1978, Science.

[20]  K. Brune,et al.  Pharmacological control of prostaglandin and thromboxane release from macrophages , 1978, Nature.

[21]  R. Schultz,et al.  Effects of whole body X-irradiation and cyclophosphamide treatment on induction of macrophage tumoricidal function in mice. , 1978, Cellular immunology.

[22]  H. Cheung,et al.  Effects of prostaglandins on the spreading, adhesion and migration of mouse peritoneal macrophages. , 1978, Prostaglandins.

[23]  K. Resch,et al.  The effects of phagocytosis, dextran sulfate, and cell damage on PGE1 sensitivity and PGE1 production of macrophages. , 1978, Journal of immunology.

[24]  R. Schultz,et al.  Similarities among factors that render macrophages tumoricidal in lymphokine and interferon preparations. , 1978, Cancer research.

[25]  R. Bockman,et al.  Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages , 1978, The Journal of experimental medicine.

[26]  H. Broxmeyer,et al.  Limitation of excessive myelopoiesis by the intrinsic modulation of macrophage-derived prostaglandin E. , 1978, Science.

[27]  V. Manganiello,et al.  Agents that increase cyclic AMP inhibit accumulation of cGMP and depress human monocyte locomotion. , 1978, Journal of immunology.

[28]  E. Hecker,et al.  Inflammatory, tumor initiating and promoting activities of polycyclic aromatic hydrocarbons and diterpene esters in mouse skin as compared with their prostaglandin releasing potency in vitro. , 1978, Cancer letters.

[29]  U. Heine,et al.  Functional and morphologic characteristics of interferon-treated macrophages. , 1978, Cellular immunology.

[30]  I. Fidler.  Recognition and destruction of target cells by tumoricidal macrophages. , 1978, Israel journal of medical sciences.

[31]  S. Russell,et al.  Functional characterization of a stable, noncytolytic stage of macrophage activation in tumors , 1977, The Journal of experimental medicine.

[32]  L. Wahl,et al.  Prostaglandin regulation of macrophage collagenase production. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Papamatheakis,et al.  Association of macrophage activation with antitumor activity by synthetic and biological agents. , 1977, Cancer research.

[34]  J. Papamatheakis,et al.  Interferon: an inducer of macrophage activation by polyanions. , 1977, Science.

[35]  M. Yaron,et al.  Stimulation of prostaglandin E production in cultured human fibroblasts by poly(I) · poly(C) and human interferon , 1977, Nature.

[36]  J. Papamatheakis,et al.  Direct activation in vitro of mouse peritoneal macrophages by pyran copolymer (NSC 46015). , 1977, Cellular immunology.

[37]  M. Ho,et al.  Cellular origin of interferon induced by bacterial lipopolysaccharide , 1977, Infection and immunity.

[38]  J. Hadden,et al.  Molecular Aspects of Macrophage Activation and Proliferation , 1977 .

[39]  Chirigos Ma.  Antitumor action of interferon: animal systems. , 1977 .

[40]  M. A. Bray,et al.  Control of lymphokine secretion by prostaglandins , 1976, Nature.

[41]  J. Vassalli,et al.  Macrophage plasminogen activator: Modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides , 1976, Cell.

[42]  P. Morahan,et al.  Macrophage activation and anti‐tumor activity of biologic and synthetic agents , 1976, International journal of cancer.

[43]  D. Gemsa,et al.  Release of cyclic AMP from macrophages by stimulation with prostaglandins. , 1975, Journal of immunology.

[44]  J. Hibbs.  Discrimination between neoplastic and non-neoplastic cells in vitro by activated macrophages. , 1974, Journal of the National Cancer Institute.

[45]  E. Remold-O’Donnell.  Stimulation and desensitization of macrophage adenylate cyclase by prostaglandins and catecholamines. , 1974, The Journal of biological chemistry.

[46]  I. Fidler.  Inhibition of pulmonary metastasis by intravenous injection of specifically activated macrophages. , 1974, Cancer research.

[47]  J. David,et al.  Prevention of MIF activity by agents known to increase cellular cyclic AMP. , 1973, Journal of immunology.

[48]  I. Gresser,et al.  Mechanism of the Antitumour Effect of Interferon in Mice , 1972, Nature.

[49]  S. Grossberg.  The interferons and their inducers: molecular and therapeutic considerations. 2. , 1972, The New England journal of medicine.

[50]  J. Sykes,et al.  Prostaglandin production by experimental tumours and effects of anti-inflammatory compounds. , 1972, Nature: New biology.

[51]  I. Gresser,et al.  Interferon and cell division. II. Influence of various experimental conditions on the inhibition of L1210 cell multiplication in vitro by interferon preparations. , 1970, Journal of the National Cancer Institute.

[52]  I. Gresser,et al.  Antitumor effects of interferon preparations in mice. , 1970, Journal of the National Cancer Institute.